Thermo Fisher Scientific Inc (TMO) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
Over the past 4 years, Thermo Fisher Scientific Inc has achieved a revenue compound annual growth rate (CAGR) of 1.0%, while earnings have grown at 2.8% CAGR.
Historical revenue and profitability trends for Thermo Fisher Scientific Inc
The chart above illustrates Thermo Fisher Scientific Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Thermo Fisher Scientific Inc's business.
How efficiently Thermo Fisher Scientific Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Thermo Fisher Scientific Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Thermo Fisher Scientific Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.3871 based on 31 analysts.
Based on our comprehensive analysis, Thermo Fisher Scientific Inc (TMO) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Thermo Fisher Scientific Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Thermo Fisher Scientific Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: TMO Valuation, TMO Dividend, TMO Financial Health
Compare: TMO vs AAPL, TMO vs MSFT, TMO vs GOOGL